Target intelligence / Profile preview

Cellular membranes of antigen-presenting and immune cells

Molecular classification
Other, Cellular structure
01

Overview

The cellular membranes of antigen-presenting cells (APCs), such as dendritic cells, macrophages, and B cells, serve as the primary interface for the initiation of the adaptive immune response. These membranes are complex lipid bilayers that house essential proteins including Major Histocompatibility Complex (MHC) molecules, co-stimulatory ligands, and various pattern recognition receptors (PRRs) that facilitate the detection of pathogens and the activation of T cells (Source: Frontiers in Immunology, 2021). In pharmacological contexts, these membranes are often the site of action for vaccine adjuvants like Alum, which interact with the plasma membrane to stimulate the NALP3 inflammasome and enhance antigen uptake (Source: Nature Immunology, 2008). Furthermore, the emerging field of biomimetic nanotechnology utilizes these membranes to coat synthetic nanoparticles, allowing them to evade the immune system or target specific tissues by mimicking the natural surface properties of immune cells (Source: Nature Nanotechnology, 2017). While critical for immune function and drug delivery, the term refers to a broad cellular compartment rather than a specific molecular target, making it a structural entity in drug development.

Other names
Immune cell plasma membraneAPC membraneLeukocyte membranePhagocyte membrane
02

Mechanism of action

Membrane-mediated adjuvant activity, biomimetic targeting, membrane fusion for nucleic acid delivery, and receptor-mediated endocytosis.

03

Biological functions

Antigen presentationCell-cell interactionSignal transductionEndocytosisExocytosisImmune responsePhagocytosis
04

Disease associations

CancerInfectionAutoimmune diseaseInflammation
05

Safety considerations

Cytokine release syndromeSystemic inflammationHypersensitivity reactionsMembrane toxicityOff-target immune activation
06

Interacting drugs

Aluminum hydroxide (Alum)

4 more in the full profile.

07

Biomarkers

MHC class II expressionCD80 (B7-1)CD86 (B7-2)CD40HLA-DR

Beyond the preview

Go deeper on Cellular membranes of antigen-presenting and immune cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular membranes of antigen-presenting and immune cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call